367 related articles for article (PubMed ID: 6801179)
1. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
Joiner KA; Hammer CH; Brown EJ; Frank MM
J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
Joiner K; Brown E; Hammer C; Warren K; Frank M
J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.
Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM
Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836
[TBL] [Abstract][Full Text] [Related]
6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
7. Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
Schiller NL; Joiner KA
Infect Immun; 1986 Dec; 54(3):689-94. PubMed ID: 3096887
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
Joiner KA; Warren KA; Tam M; Frank MM
J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
[TBL] [Abstract][Full Text] [Related]
9. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.
Tomlinson S; Taylor PW; Morgan BP; Luzio JP
Biochem J; 1989 Oct; 263(2):505-11. PubMed ID: 2597121
[TBL] [Abstract][Full Text] [Related]
10. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.
Harriman GR; Podack ER; Braude AI; Corbeil LC; Esser AF; Curd JG
J Exp Med; 1982 Oct; 156(4):1235-49. PubMed ID: 6818318
[TBL] [Abstract][Full Text] [Related]
11. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
12. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck.
Heffernan EJ; Reed S; Hackett J; Fierer J; Roudier C; Guiney D
J Clin Invest; 1992 Sep; 90(3):953-64. PubMed ID: 1522243
[TBL] [Abstract][Full Text] [Related]
14. Studies on serum resistance in Escherichia coli.
Kubens BS; Opferkuch W
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):52-65. PubMed ID: 3146846
[TBL] [Abstract][Full Text] [Related]
15. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
16. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
[TBL] [Abstract][Full Text] [Related]
17. Secretion of the terminal complement proteins, C5-C9, by human platelets.
Houle JJ; Leddy JP; Rosenfeld SI
Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
[TBL] [Abstract][Full Text] [Related]
18. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
[TBL] [Abstract][Full Text] [Related]
19. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.
Joiner KA; Schmetz MA; Sanders ME; Murray TG; Hammer CH; Dourmashkin R; Frank MM
Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4808-12. PubMed ID: 3895225
[TBL] [Abstract][Full Text] [Related]
20. Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity.
Tomlinson S; Taylor PW; Luzio JP
Biochemistry; 1990 Feb; 29(7):1852-60. PubMed ID: 2184889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
